Omid Shafaat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Omid Shafaat has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Houman Sotoudeh
The University of Texas Southwestern Medical Center, Dallas, USA
11 shared publications - Aparna Singhal
Section of Neuroradiology, Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama
7 shared publications - Clifford R. Weiss
Johns Hopkins University School of Medicine
6 shared publications - Dorry Lidor Segev
Department of Surgery New York University New York New York USA
4 shared publications - Ehsan Sotoudeh
Surgery, Iranian Hospital in Dubai, Dubai, ARE
4 shared publications - Galal Elsayed
Department of Neurological Surgery, Och Spine at New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA
4 shared publications
Latest Publications
- 1 October 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 321 (1)
Photon-counting CT in Bariatric Imaging and Body Composition: An Early Career Perspective
- 1 October 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 321 (1)
Photon-counting CT in Bariatric Imaging and Body Composition: An Early Career Perspective
- 1 October 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 321 (1)
Implications for Hepatocellular Carcinoma Ablation beyond the Tumor Margin: An Early Career Perspective
- 1 October 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 321 (1)
Implications for Hepatocellular Carcinoma Ablation beyond the Tumor Margin: An Early Career Perspective
- 15 October 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (1) , 118-129
Association of Myosteatosis and of Graft Loss after Kidney Transplantation
Key Points: Myosteatosis was associated with a higher risk of all-cause graft loss and mortality within the US cohort. Myosteatosis did not show an higher risk of death censored graft loss at both centers. Sarcopenia was not associated with a higher risk of all-cause graft loss or mortality. Background: Sarcopenia and myosteatosis are indicators of abnormal body composition (BC). Computed tomography (CT) imaging has proven to be an accurate modality for BC quantification in kidney transplantation (KT). We tested whether pre-KT CT-based BC was associated with both all-cause graft loss (ACGL) and mortality among adult recipients from two centers (Johns Hopkins Hospital [JHH] and University Medical Center Groningen [UMCG]). Methods: Patients who underwent a KT between 2003 and 2020 were followed for a median (interquartile range) follow-up of 6.4 (4.6–8.5) years at JHH and 6.3 (5.1–7.5) years at UMCG. Cox proportional hazard models were used to estimate the associations of BC with ACGL/mortality. Fine and Gray regression analysis was performed to assess the association between BC and death-censored graft loss. Before KT, 49% of recipients had sarcopenia and 66% had myosteatosis. Results: In total, 608 patients were included from JHH ( N =294) and UMCG ( N =314). Sarcopenia was not associated with post-KT outcomes. Myosteatosis was associated with a higher risk of ACGL (adjusted hazard ratio, 1.78; 95% confidence interval, 1.08 to 2.93) and mortality (adjusted hazard ratio, 2.35; 95% confidence interval, 1.27 to 4.33) at JHH but showed no significant association at UMCG after adjusting for confounders. Myosteatosis did not show a significant association with death-censored graft loss at both centers. Conclusions: Myosteatosis ascertained from existing CT scans could help identify recipients at higher risk for ACGL who may benefit most from prehabilitation.
- 15 October 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (1) , 118-129
Association of Myosteatosis and of Graft Loss after Kidney Transplantation
Key Points: Myosteatosis was associated with a higher risk of all-cause graft loss and mortality within the US cohort. Myosteatosis did not show an higher risk of death censored graft loss at both centers. Sarcopenia was not associated with a higher risk of all-cause graft loss or mortality. Background: Sarcopenia and myosteatosis are indicators of abnormal body composition (BC). Computed tomography (CT) imaging has proven to be an accurate modality for BC quantification in kidney transplantation (KT). We tested whether pre-KT CT-based BC was associated with both all-cause graft loss (ACGL) and mortality among adult recipients from two centers (Johns Hopkins Hospital [JHH] and University Medical Center Groningen [UMCG]). Methods: Patients who underwent a KT between 2003 and 2020 were followed for a median (interquartile range) follow-up of 6.4 (4.6–8.5) years at JHH and 6.3 (5.1–7.5) years at UMCG. Cox proportional hazard models were used to estimate the associations of BC with ACGL/mortality. Fine and Gray regression analysis was performed to assess the association between BC and death-censored graft loss. Before KT, 49% of recipients had sarcopenia and 66% had myosteatosis. Results: In total, 608 patients were included from JHH ( N =294) and UMCG ( N =314). Sarcopenia was not associated with post-KT outcomes. Myosteatosis was associated with a higher risk of ACGL (adjusted hazard ratio, 1.78; 95% confidence interval, 1.08 to 2.93) and mortality (adjusted hazard ratio, 2.35; 95% confidence interval, 1.27 to 4.33) at JHH but showed no significant association at UMCG after adjusting for confounders. Myosteatosis did not show a significant association with death-censored graft loss at both centers. Conclusions: Myosteatosis ascertained from existing CT scans could help identify recipients at higher risk for ACGL who may benefit most from prehabilitation.
- Open Access
- 8 November 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (4) , 591-605
Abdominal computed tomography measurements of body composition and waitlist mortality in kidney transplant candidates
- 8 November 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (4) , 591-605
Open AccessAbdominal computed tomography measurements of body composition and waitlist mortality in kidney transplant candidates
- Open Access
- 13 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e25917
Radiological and Clinical Findings of Non-bifurcating Carotid Artery With Aberrant Course: A Case Report and Review of the Literature
A non-bifurcating carotid artery is a rare variation in the carotid circulation. Here we present a rare case of a non-bifurcating carotid artery with an aberrant course of the internal carotid artery incidentally discovered in a patient who presented to the trauma center after a fall. To our knowledge, this is the first reported case of a non-bifurcating carotid artery with an aberrant course of the internal carotid artery. The embryonic mechanisms of this variation and the available literature regarding this condition are also reviewed. Knowing this variation is necessary before considering vascular intervention of the neck and ear surgery to avoid vascular injury and complications.
- 13 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e25917
Open AccessRadiological and Clinical Findings of Non-bifurcating Carotid Artery With Aberrant Course: A Case Report and Review of the Literature
A non-bifurcating carotid artery is a rare variation in the carotid circulation. Here we present a rare case of a non-bifurcating carotid artery with an aberrant course of the internal carotid artery incidentally discovered in a patient who presented to the trauma center after a fall. To our knowledge, this is the first reported case of a non-bifurcating carotid artery with an aberrant course of the internal carotid artery. The embryonic mechanisms of this variation and the available literature regarding this condition are also reviewed. Knowing this variation is necessary before considering vascular intervention of the neck and ear surgery to avoid vascular injury and complications.
- 1 June 2022
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 49 (4) , 343-351
Leveraging artificial intelligence in ischemic stroke imaging
- 1 June 2022
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 49 (4) , 343-351
Leveraging artificial intelligence in ischemic stroke imaging
- Open Access
- 29 April 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (9) , 2277-2278
Moving toward clinical implementation of the physical frailty phenotype in kidney transplantation
- 29 April 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (9) , 2277-2278
Open AccessMoving toward clinical implementation of the physical frailty phenotype in kidney transplantation
- Open Access
- 8 January 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (4) , 1145-1157
Revision of frailty assessment in kidney transplant recipients: Replacing unintentional weight loss with CT-assessed sarcopenia in the physical frailty phenotype
- 8 January 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (4) , 1145-1157
Open AccessRevision of frailty assessment in kidney transplant recipients: Replacing unintentional weight loss with CT-assessed sarcopenia in the physical frailty phenotype
- Open Access
- 1 December 2021
- Published by Springer Nature in Cureus
- Vol. 13 (12) , e20080
Emerging Applications of Radiomics in Neurological Disorders: A Review
Radiomics has achieved significant momentum in radiology research and can reveal image information invisible to radiologists’ eyes. Radiomics first evolved for oncologic imaging. Oncologic applications (histopathology, tumor grading, gene mutation analysis, patient survival, and treatment response prediction) of radiomics are widespread. However, it is not limited to oncologic analysis, and any digital medical images can benefit from radiomics analysis. This article reviews the current literature on radiomics in non-oncologic, neurological disorders including ischemic strokes, hemorrhagic stroke, cerebral aneurysms, and demyelinating disorders.
- 1 December 2021
- Published by Springer Nature in Cureus
- Vol. 13 (12) , e20080
Open AccessEmerging Applications of Radiomics in Neurological Disorders: A Review
Radiomics has achieved significant momentum in radiology research and can reveal image information invisible to radiologists’ eyes. Radiomics first evolved for oncologic imaging. Oncologic applications (histopathology, tumor grading, gene mutation analysis, patient survival, and treatment response prediction) of radiomics are widespread. However, it is not limited to oncologic analysis, and any digital medical images can benefit from radiomics analysis. This article reviews the current literature on radiomics in non-oncologic, neurological disorders including ischemic strokes, hemorrhagic stroke, cerebral aneurysms, and demyelinating disorders.
- Open Access
- 14 October 2021
- Published by Springer Nature in Cureus
- Vol. 13 (10)
Accuracy of Machine Learning Models to Predict Mortality in COVID-19 Infection Using the Clinical and Laboratory Data at the Time of Admission
This study aimed to develop a predictive model to predict patients’ mortality with coronavirus disease 2019 (COVID-19) from the basic medical data on the first day of admission. The medical data including the demographic, clinical, and laboratory features on the first day of admission of clinically diagnosed COVID-19 patients were documented. The outcome of patients was also recorded as discharge or death. Feature selection models were then implemented and different machine learning models were developed on top of the selected features to predict discharge or death. The trained models were then tested on the test dataset. A total of 520 patients were included in the training dataset. The feature selection demonstrated 22 features as the most powerful predictive features. Among different machine learning models, the naive Bayes demonstrated the best performance with an area under the curve of 0.85. The ensemble model of the naive Bayes and neural network combination had slightly better performance with an area under the curve of 0.86. The models had relatively the same performance on the test dataset. Developing a predictive machine learning model based on the basic medical features on the first day of admission in COVID-19 infection is feasible with acceptable performance.
- 14 October 2021
- Published by Springer Nature in Cureus
- Vol. 13 (10)
Open AccessAccuracy of Machine Learning Models to Predict Mortality in COVID-19 Infection Using the Clinical and Laboratory Data at the Time of Admission
This study aimed to develop a predictive model to predict patients’ mortality with coronavirus disease 2019 (COVID-19) from the basic medical data on the first day of admission. The medical data including the demographic, clinical, and laboratory features on the first day of admission of clinically diagnosed COVID-19 patients were documented. The outcome of patients was also recorded as discharge or death. Feature selection models were then implemented and different machine learning models were developed on top of the selected features to predict discharge or death. The trained models were then tested on the test dataset. A total of 520 patients were included in the training dataset. The feature selection demonstrated 22 features as the most powerful predictive features. Among different machine learning models, the naive Bayes demonstrated the best performance with an area under the curve of 0.85. The ensemble model of the naive Bayes and neural network combination had slightly better performance with an area under the curve of 0.86. The models had relatively the same performance on the test dataset. Developing a predictive machine learning model based on the basic medical features on the first day of admission in COVID-19 infection is feasible with acceptable performance.